Knight Therapeutics Inc.
KHTRF
$6.59
$0.111.70%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 3.95M | -4.00M | -2.68M | 130.90K | 7.83M |
| Total Depreciation and Amortization | 43.43M | 39.86M | 39.06M | 35.98M | 36.83M |
| Total Amortization of Deferred Charges | 705.10K | 705.10K | 662.90K | 662.90K | 662.90K |
| Total Other Non-Cash Items | 12.72M | 11.46M | 4.22M | 575.50K | -5.30M |
| Change in Net Operating Assets | 15.49M | 1.57M | -15.63M | -15.43M | -33.53M |
| Cash from Operations | 76.29M | 49.59M | 25.62M | 21.92M | 6.49M |
| Capital Expenditure | -3.50M | -1.37M | -1.41M | -1.38M | -1.44M |
| Sale of Property, Plant, and Equipment | 0.00 | 20.90K | 92.30K | 92.30K | 94.50K |
| Cash Acquisitions | -79.57M | -79.57M | -79.57M | -77.25M | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 13.09M | 25.78M | 41.93M | 49.06M | 53.66M |
| Cash from Investing | -69.98M | -55.14M | -38.95M | -29.48M | 52.32M |
| Total Debt Issued | 110.26M | 112.07M | 111.75M | 113.38M | 4.74M |
| Total Debt Repaid | -103.27M | -93.44M | -71.56M | -69.59M | -21.62M |
| Issuance of Common Stock | 734.00K | 736.00K | 743.00K | 1.07M | 1.04M |
| Repurchase of Common Stock | -11.24M | -6.35M | -8.50M | -10.98M | -12.21M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -7.68M | -7.60M | -7.57M | -7.05M | -7.29M |
| Cash from Financing | -7.85M | 4.20M | 18.19M | 19.60M | -25.43M |
| Foreign Exchange rate Adjustments | -1.50M | -2.08M | 135.80K | -500.80K | 1.49M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.04M | -3.43M | 5.00M | 11.54M | 34.88M |